Skip to main content

Advertisement

Log in

The effects of zoledronic acid treatment and endurance exercise on ovariectomy-induced osteopenia in Wistar rats

  • Research
  • Published:
Sport Sciences for Health Aims and scope Submit manuscript

Abstract

Background

This study investigated the effects of endurance exercise training and zoledronic acid (Zol) treatment on ovariectomy-induced osteopenia.

Methods

Middle-aged female Wistar rats were subjected to sham and ovariectomy surgeries and assigned to seven different groups according to Zol treatment doses and treadmill endurance exercise (Ex) training; these were the Sham, Ovx, Ovx + LowZ, Ovx + HighZ, Ovx + Ex, Ovx + LowZ + Ex, Ovx + HighZ + Ex groups. The subcutaneous doses for the low- and high-Zol-treated ovariectomized rats were 20 and 100 µg/kg, respectively. Total intervention period was 10 weeks.

Results

When comparing the Ovx groups to the Sham group, ovariectomy resulted in multiple compromises in bone histomorphometry, size-related measurements, and biomechanical properties. Two-way ANOVA was adopted to investigate the effects of Zol treatments and Ex on the six ovariectomized groups. In spongy bone histomorphometry, Zol treatment resulted in comprehensive preservation for all parameters, while exercise demonstrated benefits for osteoclastic number and mineralization activity. In serum marker assays, the Zol-treated rats had lower serum osteocalcin and IGF-1/IGFBP-3 molar ratio when compared to the non-treated rats. Exercise training significantly benefited metabolism through lower serum triglycerides, cholesterol, leptin, IGF-1 and IGF-1/IGFBP-3 molar ratio, along with increased IGFBP-3 and phosphorus (p < 0.05). In bone-size-related measurements and biomechanical property analyses, data were normalized to body weight. For whole bone strength, Zol treatments demonstrated higher bone fracture load (FL) and FL energy, while Ex showed benefits to yield load, FL, post-yield load energy, and stiffness. In tissue-level biomechanical properties, rats treated with the higher Zol dose were higher in yield stress and yield toughness. Exercise benefited most bone-size-related measurements, while the high Zol-treated rats showed smaller medullar area.

Conclusion

When combined with Zol treatments, exercise training did not demonstrate significant collaborative or modifying effects. Exercise and bisphosphonate tend to affect to bone through distinct pathways. A lower dose or different timing of Zol treatment or during a later phase of bisphosphonate treatment (drug holiday) might allow the occurrence of synergistic effects between Zol treatment and exercise.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Availability of data and materials

All data generated or analyzed during this study are included in this published article.

Abbreviations

BMD:

Bone mineral density

BMC:

Bone mineral content

Zol:

Zoledronic acid

IGF-1:

Insulin-like growth factor-1

LI-IGF-1 / :

Liver-specific IGF-1 inactivation

LowZ and HighZ:

Zol treatment dose at 20 and 100 µg/kg, respectively

EXE:

Endurance running training

MMA:

Methyl methacrylate

EDTA:

Ethylenediaminetetraacetic acid

BV/TV:

Bone volume ratio (%), Tb.Th.: trabecular thickness (μm)

Tb.Sp.:

Space between trabeculae (μm)

Tb.No.:

Trabeculae number (1/mm)

MS/BS:

Bone mineralization over bone surface (%)

TRAP:

Tartrate-resistant acid phosphatase

IGFBP-3:

Insulin-like growth factor binding protein-3

YL:

Yield load

FL:

Fracture load

FFDW:

Fat-free dry weight

Ct.Th.:

Cortical thickness (mm)

CS.Ar.:

Total cross-sectional area (mm2)

Ct.Ar.:

Cortical area (mm2)

Me.Ar.:

Medullar area (mm2)

CSMI:

Cross-sectional moment of inertia (mm4)

YS:

Yield stress

YT:

Yield toughness

EM:

Elastic modulus

References

  1. Nancollas GH, Tang R, Phipps RJ, Henneman Z, Gulde S, Wu W, Mangood A, Russell RG, Ebetino FH (2006) Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite. Bone 38:617–627

    Article  CAS  PubMed  Google Scholar 

  2. Lewiecki EM (2008) Intravenous zoledronic acid for the treatment of osteoporosis. Current Osteoporos Rep 6:17–23

    Article  Google Scholar 

  3. Grey A, Bolland M, Wattie D, Horne A, Gamble G, Reid IR (2010) Prolonged antiresorptive activity of zoledronate: a randomized, controlled trial. J Bone Miner Res 25:2251–2255

    Article  CAS  PubMed  Google Scholar 

  4. Reid IR, Horne AM, Mihov B, Stewart A, Garratt E, Wong S, Wiessing KR, Bolland MJ, Bastin S, Gamble GD (2018) Fracture prevention with zoledronate in older women with osteopenia. N Engl J Med 379:2407–2416

    Article  CAS  PubMed  Google Scholar 

  5. Gasser JA, Ingold P, Venturiere A, Shen V, Green JR (2008) Long-term protective effects of zoledronic acid on cancellous and cortical bone in the ovariectomized rat. J Bone Miner Res 23:544–551

    Article  CAS  PubMed  Google Scholar 

  6. Khajuria DK, Razdan R, Mahapatra DR, Bhat MR (2013) Osteoprotective effect of propranolol in ovariectomized rats: a comparison with zoledronic acid and alfacalcidol. J Orthop Sci 18:832–842

    Article  CAS  PubMed  Google Scholar 

  7. Khajuria DK, Razdan R, Mahapatra DR (2014) The combination therapy with zoledronic Acid and propranolol improves the trabecular microarchitecture and mechanical property in an rat model of postmenopausal osteoporosis. J Osteoporos 2014:586431

    Article  PubMed  PubMed Central  Google Scholar 

  8. Khajuria DK, Razdan R, Mahapatra DR (2015) Additive effects of zoledronic acid and propranolol on bone density and biochemical markers of bone turnover in osteopenic ovariectomized rats. Rev Bras Reumatol 55:103–112

    Article  PubMed  Google Scholar 

  9. Orwoll ES, Miller PD, Adachi JD, Brown J, Adler RA, Kendler D, Bucci-Rechtweg C, Readie A, Mesenbrink P, Weinstein RS (2010) Efficacy and safety of a once-yearly i.v. infusion of zoledronic acid 5 mg versus a once-weekly 70-mg oral alendronate in the treatment of male osteoporosis: a randomized, multicenter, double-blind, active-controlled study. J Bone Miner Res 25:2239–2250

    Article  CAS  PubMed  Google Scholar 

  10. Allen MR, Burr DB (2011) Bisphosphonate effects on bone turnover, microdamage, and mechanical properties: what we think we know and what we know that we don’t know. Bone 49:56–65

    Article  CAS  PubMed  Google Scholar 

  11. Lee JK (2009) Bilateral atypical femoral diaphyseal fractures in a patient treated with alendronate sodium. Int J Rheum Dis 12:149–154

    Article  PubMed  Google Scholar 

  12. Shane E, Burr D, Ebeling PR et al (2010) Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 25:2267–2294

    Article  PubMed  Google Scholar 

  13. Rogers LF, Taljanovic M (2010) FDA statement on relationship between bisphosphonate use and atypical subtrochanteric and femoral shaft fractures: a considered opinion. AJR Am J Roentgenol 195:563–566

    Article  PubMed  Google Scholar 

  14. Shane E, Burr D, Abrahamsen B et al (2014) Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 29:1–23

    Article  PubMed  Google Scholar 

  15. Lespessailles E, Jaffre C, Beaupied H, Nanyan P, Dolleans E, Benhamou CL, Courteix D (2009) Does exercise modify the effects of zoledronic acid on bone mass, microarchitecture, biomechanics, and turnover in ovariectomized rats? Calcif Tissue Int 85:146–157

    Article  CAS  PubMed  Google Scholar 

  16. Tamaki H, Akamine T, Goshi N, Kurata H, Sakou T (1998) Effects of exercise training and etidronate treatment on bone mineral density and trabecular bone in ovariectomized rats. Bone 23:147–153

    Article  CAS  PubMed  Google Scholar 

  17. Uusi-Rasi K, Kannus P, Cheng S et al (2003) Effect of alendronate and exercise on bone and physical performance of postmenopausal women: a randomized controlled trial. Bone 33:132–143

    Article  CAS  PubMed  Google Scholar 

  18. Uusi-Rasi K, Sievanen H, Heinonen A, Kannus P, Vuori I (2004) Effect of discontinuation of alendronate treatment and exercise on bone mass and physical fitness: 15-month follow-up of a randomized, controlled trial. Bone 35:799–805

    Article  CAS  PubMed  Google Scholar 

  19. Chilibeck PD, Davison KS, Whiting SJ, Suzuki Y, Janzen CL, Peloso P (2002) The effect of strength training combined with bisphosphonate (etidronate) therapy on bone mineral, lean tissue, and fat mass in postmenopausal women. Can J Physiol Pharmacol 80:941–950

    Article  CAS  PubMed  Google Scholar 

  20. Fuchs RK, Shea M, Durski SL, Winters-Stone KM, Widrick J, Snow CM (2007) Individual and combined effects of exercise and alendronate on bone mass and strength in ovariectomized rats. Bone 41:290–296

    Article  CAS  PubMed  Google Scholar 

  21. Waltman NL, Twiss JJ, Ott CD, Gross GJ, Lindsey AM, Moore TE, Berg K, Kupzyk K (2010) The effect of weight training on bone mineral density and bone turnover in postmenopausal breast cancer survivors with bone loss: a 24-month randomized controlled trial. Osteoporos Int 21:1361–1369

    Article  CAS  PubMed  Google Scholar 

  22. Paliologo T, Shimano RC, Shimano AC, Macedo AP, Falcai MJ, Issa JPM (2015) Effects of swimming associated with risedronate in osteopenic bones: an experimental study with ovariectomized rats. Micron 78:40–44

    Article  CAS  PubMed  Google Scholar 

  23. Shimano RC, Macedo AP, Falcai MJ, Ervolino E, Shimano AC, Issa JP (2014) Biomechanical and microstructural benefits of physical exercise associated with risedronate in bones of ovariectomized rats. Microsc Res Tech 77:431–438

    Article  CAS  PubMed  Google Scholar 

  24. Weitzmann MN, Pacifici R (2006) Estrogen deficiency and bone loss: an inflammatory tale. J Clin Investig 116:1186–1194

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Weitzmann MN (2017) Bone and the immune system. Toxicol Pathol 45:911–924

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Huang TH (2015) The skeleton modeled by endurance exercise and dietary manipulation: a perspective from the Interaction between bone metabolism and energy metabolism. Phys Educ J 48:1–17

    Google Scholar 

  27. Lindberg MK, Svensson J, Venken K, Chavoshi T, Andersson N, Moverare Skrtic S, Isaksson O, Vanderschueren D, Carlsten H, Ohlsson C (2006) Liver-derived IGF-I is permissive for ovariectomy-induced trabecular bone loss. Bone 38:85–92

    Article  CAS  PubMed  Google Scholar 

  28. Pichini S, Ventura R, Palmi I et al (2010) Effect of physical fitness and endurance exercise on indirect biomarkers of growth hormone and insulin misuse: Immunoassay-based measurement in urine samples. J Pharm Biomed Anal 53:1003–1010

    Article  CAS  PubMed  Google Scholar 

  29. Wieczorek-Baranowska A, Nowak A, Michalak E, Karolkiewicz J, Pospieszna B, Rutkowski R, Laurentowska M, Pilaczynska-Szczesniak L (2011) Effect of aerobic exercise on insulin, insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in overweight and obese postmenopausal women. J Sports Med Phys Fit 51:525–532

    CAS  Google Scholar 

  30. Nishida Y, Matsubara T, Tobina T, Shindo M, Tokuyama K, Tanaka K, Tanaka H (2010) Effect of low-intensity aerobic exercise on insulin-like growth factor-I and insulin-like growth factor-binding proteins in healthy men. Int J Endocrinol 2010:452820

    Article  PubMed  PubMed Central  Google Scholar 

  31. Grandys M, Majerczak J, Kuczek P, Sztefko K, Duda K, Zoladz JA (2017) Endurance training-induced changes in the GH-IGF-I axis influence maximal muscle strength in previously untrained men. Growth Horm IGF Res 32:41–48

    Article  CAS  PubMed  Google Scholar 

  32. Sengupta P (2013) The laboratory rat: relating its age with human’s. Int J Prev Med 4:624–630

    PubMed  PubMed Central  Google Scholar 

  33. Khajuria DK, Razdan R, Mahapatra DR (2012) Description of a new method of ovariectomy in female rats. Rev Bras Reumatol 52:462–470

    PubMed  Google Scholar 

  34. Park SB, Lee YJ, Chung CK (2010) Bone mineral density changes after ovariectomy in rats as an osteopenic model : stepwise description of double dorso-lateral approach. J Korean Neurosurg Soc 48:309–312

    Article  PubMed  PubMed Central  Google Scholar 

  35. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR (1987) Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2:595–610

    Article  CAS  PubMed  Google Scholar 

  36. Janssen JA, Lamberts SW (2004) Igf-I and longevity. Horm Res 62(Suppl 3):104–109

    CAS  PubMed  Google Scholar 

  37. Huang TH, Lin SC, Chang FL, Hsieh SS, Liu SH, Yang RS (2003) Effects of different exercise modes on mineralization, structure, and biomechanical properties of growing bone. J Appl Physiol 95:300–307

    Article  CAS  PubMed  Google Scholar 

  38. Honda A, Umemura Y, Nagasawa S (2001) Effect of high-impact and low-repetition training on bones in ovariectomized rats. J Bone Miner Res 16:1688–1693

    Article  CAS  PubMed  Google Scholar 

  39. Turner CH, Burr DB (1993) Basic biomechanical measurements of bone: a tutorial. Bone 14:595–608

    Article  CAS  PubMed  Google Scholar 

  40. Biewener AA (1991) Musculoskeletal design in relation to body size. J Biomech 24(Suppl 1):19–29

    Article  PubMed  Google Scholar 

  41. Wronski TJ, Cintron M, Dann LM (1988) Temporal relationship between bone loss and increased bone turnover in ovariectomized rats. Calcif Tissue Int 43:179–183

    Article  CAS  PubMed  Google Scholar 

  42. Riggs BL, Khosla S, Melton LJ 3rd (2002) Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev 23:279–302

    Article  CAS  PubMed  Google Scholar 

  43. Rissanen JP, Suominen MI, Peng Z, Halleen JM (2008) Secreted tartrate-resistant acid phosphatase 5b is a Marker of osteoclast number in human osteoclast cultures and the rat ovariectomy model. Calcif Tissue Int 82:108–115

    Article  CAS  PubMed  Google Scholar 

  44. Kalu DN, Arjmandi BH, Liu CC, Salih MA, Birnbaum RS (1994) Effects of ovariectomy and estrogen on the serum levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3. Bone Miner 25:135–148

    Article  CAS  PubMed  Google Scholar 

  45. Skedros JG, Dayton MR, Sybrowsky CL, Bloebaum RD, Bachus KN (2006) The influence of collagen fiber orientation and other histocompositional characteristics on the mechanical properties of equine cortical bone. J Exp Biol 209:3025–3042

    Article  PubMed  Google Scholar 

  46. Burr DB, Diab T, Koivunemi A, Koivunemi M, Allen MR (2009) Effects of 1 to 3 years’ treatment with alendronate on mechanical properties of the femoral shaft in a canine model: implications for subtrochanteric femoral fracture risk. J Orthop Res 27:1288–1292

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Bajaj D, Geissler JR, Allen MR, Burr DB, Fritton JC (2014) The resistance of cortical bone tissue to failure under cyclic loading is reduced with alendronate. Bone 64:57–64

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Fairey AS, Courneya KS, Field CJ, Bell GJ, Jones LW, Mackey JR (2003) Effects of exercise training on fasting insulin, insulin resistance, insulin-like growth factors, and insulin-like growth factor binding proteins in postmenopausal breast cancer survivors: a randomized controlled trial. Cancer Epidemiol Biomark Prev 12:721–727

    CAS  Google Scholar 

  49. Campbell PT, Gross MD, Potter JD, Schmitz KH, Duggan C, McTiernan A, Ulrich CM (2010) Effect of exercise on oxidative stress: a 12-month randomized, controlled trial. Med Sci Sports Exer 42:1448–1453

    Article  CAS  Google Scholar 

  50. Pitocco D, Collina MC, Musella T, Ruotolo V, Caputo S, Manto A, Caradonna P, Galli M, Mancini L, Ghirlanda G (2008) Interaction between IGF-1, inflammation, and neuropathy in the pathogenesis of acute charcot neuroarthropathy: lessons from alendronate therapy and future perspectives of medical therapy. Horm Metab Res 40:163–164

    Article  CAS  PubMed  Google Scholar 

  51. Polidoulis I, Beyene J, Cheung AM (2012) The effect of exercise on pQCT parameters of bone structure and strength in postmenopausal women–a systematic review and meta-analysis of randomized controlled trials. Osteoporos Int 23:39–51

    Article  CAS  PubMed  Google Scholar 

  52. Kemmler W, von Stengel S, Bebenek M, Engelke K, Hentschke C, Kalender WA (2012) Exercise and fractures in postmenopausal women: 12-year results of the Erlangen Fitness and Osteoporosis Prevention Study (EFOPS). Osteoporos Int 23:1267–1276

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

Jae Cody is deeply appreciated for her editorial assistance.

Funding

This study was supported by a grant from the National Science Council (NSC 97–2410-H-006–083-MY2, TAIWAN).

Author information

Authors and Affiliations

Authors

Contributions

HS. L and TH. H prepared figures, tables and conducted the whole animal experiment; JL. L provided the expertise in calculations of material properties; MS. C provided expertise in serum analyses; AT. H conducted the tissue biomechanical test; HS. L, RS. Y, and TH. H wrote the draft of manuscript. JL. L contributed to review and editing. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Tsang-Hai Huang.

Ethics declarations

Conflict of interest

The authors declare that there is no conflict of interest.

Ethics approval and consent to participate

The procedures of animal experimentation throughout this study were approved by the Committee of Animal Study at National Cheng Kung University (Document Serial No. 97112).

Consent for publication

Not applicable.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 23 kb)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lin, HS., Yang, RS., Lewis, J.L. et al. The effects of zoledronic acid treatment and endurance exercise on ovariectomy-induced osteopenia in Wistar rats. Sport Sci Health (2024). https://doi.org/10.1007/s11332-024-01181-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s11332-024-01181-0

Keywords

Navigation